Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
29.96
-0.45 (-1.48%)
Nov 22, 2024, 4:00 PM EST - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 197 employees as of December 31, 2023. The number of employees decreased by 10 or -4.83% compared to the previous year.
Employees
197
Change (1Y)
-10
Growth (1Y)
-4.83%
Revenue / Employee
$3,041,853
Profits / Employee
$449,716
Market Cap
966.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Owens & Minor | 22,200 |
AMN Healthcare Services | 3,585 |
Phibro Animal Health | 1,940 |
HealthStream | 1,092 |
Weave Communications | 844 |
Vir Biotechnology | 587 |
Cogent Biosciences | 164 |
89bio | 70 |
COLL News
- 8 days ago - Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD) - GlobeNewsWire
- 15 days ago - Collegium Pharmaceutical, Inc. (COLL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Collegium Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology - GlobeNewsWire
- 6 months ago - Collegium to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire